Picture of Kyntra Bio logo

KYNB — Kyntra Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

FibroGen sells China unit to AstraZeneca in deal worth $160 million

Feb 20 (Reuters) - FibroGen  FGEN.O  said on Thursday
that it has sold its China unit to AstraZeneca  AZN.L  for about
$160 million. 

 (Reporting by Sneha S K; Editing by Shailesh Kuber)
 ((Sneha.SK@thomsonreuters.com;))

Recent news on Kyntra Bio

See all news